MUR Form 144: Proposed sale of common shares

MUR: Form 144 reports proposed sale of common stock.

Rhea-AI Filing Summary

MUR: Form 144 reports proposed sale of common stock. The filing lists securities to be sold including 6,660 shares tied to equity vesting on 01/31/2023 and 1,948 shares tied to equity vesting on 02/02/2024. The broker shown is Merrill Lynch and the securities are listed on NYSE.

Insights

Corporate Governance Analyst

Form 144 lists planned share sales; quantities and vesting dates are given, with broker identified.

The excerpt includes per‑lot quantities: 6,660 shares (vesting 01/31/2023) and 1,948 shares (vesting 02/02/2024). These entries are shown as equity vesting items and are associated with a broker, Merrill Lynch.

Holder decisions and timing will determine actual market activity; the excerpt does not describe proceeds or specific sale methods. Subsequent SEC submissions or broker reports may disclose executed transactions.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the MUR Form 144 report?

The filing reports proposed sales of common stock by an affiliate. It lists 6,660 shares with a vesting date of 01/31/2023 and 1,948 shares with a vesting date of 02/02/2024, and names Merrill Lynch as the broker.

Who is the broker listed on the MUR Form 144?

The broker shown is Merrill Lynch. The filing entry gives a Merrill Lynch address at 2200 N Rodney Parham Rd, Little Rock, AR, and identifies the market as NYSE for the common stock referenced.

How many shares are cited as tied to equity vesting in the filing?

The excerpt cites two vesting amounts: 6,660 shares and 1,948 shares. Those amounts are labeled as equity vesting with dates 01/31/2023 and 02/02/2024, respectively, in the Form 144 excerpt.

Does the filing state when the shares will be sold?

Timing of actual sales is not detailed in the excerpt. The document lists vesting dates for equity items (01/31/2023 and 02/02/2024) and identifies the broker, but sale execution timing is not described in the provided lines.

Does the Form 144 show proceeds or sale methods for MUR shares?

The excerpt does not disclose proceeds or detailed sale methods. It lists equity vesting entries and a broker (Merrill Lynch) and indicates the securities are common stock on the NYSE, without showing aggregate proceeds.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/03/2026 - 03:55 PM EST Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001751691
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	MURPHY OIL CORPORATION
SEC File Number	001-08590
Address of Issuer	9805 KATY FWY STE G-200 HOUSTON TEXAS 77024
Phone	281-675-9000
Name of Person for Whose Account the Securities are To Be Sold	MARIA MARTINEZ
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	OFFICER

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
COMMON	MERRILL LYNCH 2200 N RODNEY PARHAM RD STE 300 LITTLE ROCK AR 72212	8608	300650.26	142830352	03/03/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
COMMON	01/31/2023	EQUITY VESTING	ISSUER			6660	01/31/2023	N/A
COMMON	02/02/2024	EQUITY VESTING	ISSUER			1948	02/02/2024	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	03/03/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	MARIA MARTINEZ
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)